PABLO
ROJO CONEJO

Profesor titular de universidad

Foto de PABLO

Foto de Baylor College of Medicine Children’s Foundation

Baylor College of Medicine Children’s Foundation

Kampala, Uganda

Publicacións en colaboración con investigadores/as de Baylor College of Medicine Children’s Foundation (4)

2023

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
eClinicalMedicine, Vol. 60

2022

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
The Lancet HIV, Vol. 9, Núm. 5, pp. e341-e352

2021

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
BMC infectious diseases, Vol. 21, Núm. 1, pp. 5

2020

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
The Lancet HIV, Vol. 7, Núm. 8, pp. e533-e544